Ampyra and Cefuroxime drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ampyra (dalfampridine) and Cefuroxime (cefuroxime sodium). Common drug interactions include tendonitis among females and ileus among males.
The phase IV clinical study analyzes what interactions people have when they take Ampyra and Cefuroxime. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Ampyra?
Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.
What is Cefuroxime?
Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.
29 people who take Ampyra and Cefuroxime together, and have interactions are studied.

What are the common drug interactions of Ampyra and Cefuroxime, by gender? *:
female:
- Tendonitis (a condition that causes pain and swelling of tendons)
- Breast cancer recurrent
- Cardiac failure congestive
- Tremor (trembling or shaking movements in one or more parts of your body)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Fall
- Gait disturbance
- Ill-defined disorder
- Mobility decreased (ability to move is reduced)
- Burning sensation
male:
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Septic shock (shock due to blood infection)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Fatigue (feeling of tiredness)
- Hypoaesthesia (reduced sense of touch or sensation)
- Muscular weakness (muscle weakness)
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
What are the common drug interactions of Ampyra and Cefuroxime, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Drug ineffective
- Abasia (inability to walk)
40-49:
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Septic shock (shock due to blood infection)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Fatigue (feeling of tiredness)
- Hypoaesthesia (reduced sense of touch or sensation)
- Muscular weakness (muscle weakness)
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
50-59:
- Constipation
- Dyspepsia (indigestion)
60+:
- Drug hypersensitivity
- Breast cancer recurrent
- Restless legs syndrome (a powerful urge to move your legs)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Fall
- Ill-defined disorder
- Micturition urgency (urgency to pass the urine)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Pruritus (severe itching of the skin)
- Cardiac failure congestive
What are the existing conditions these people have? *
- High Blood Pressure: 8 people, 27.59%
- Dyspnea (difficult or laboured breathing): 6 people, 20.69%
- Pain: 6 people, 20.69%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 13.79%
- Migraine (headache): 4 people, 13.79%
- Headache (pain in head): 4 people, 13.79%
- Cough: 3 people, 10.34%
- Bacterial Infection: 2 people, 6.90%
- Blood Testosterone Decreased: 2 people, 6.90%
- Constipation: 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Ampyra and Cefuroxime?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ampyra (77,145 reports)
- Cefuroxime (12,999 reports)
Browse all drug interactions of Ampyra and Cefuroxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ampyra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cefuroxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ampyra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefuroxime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dalfampridine and cefuroxime sodium (the active ingredients of Ampyra and Cefuroxime, respectively), and Ampyra and Cefuroxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Renvela and Ambien - a second ago
- Esomeprazole Magnesium and Vomiting for Men aged 60+ - 10 seconds ago
- Esomeprazole Magnesium and Upset Stomach for Men aged 60+ - 10 seconds ago
- Lower Extremity Mass and drugs of ingredients of darbepoetin alfa - 10 seconds ago
- Esomeprazole Magnesium and Stomach Upset for Men aged 60+ - 11 seconds ago
- Esomeprazole Magnesium and Emesis for Men aged 60+ - 11 seconds ago
- Lopurin and Tasigna drug interactions for men aged 30-39 - 11 seconds ago
- Esomeprazole Magnesium and Nausea And Vomiting for Men aged 60+ - 11 seconds ago
- Could Paroxetine cause Drooling? - 26 seconds ago
- Blockage Of Leg Arteries in Xanax, how severe and when it was recovered? - 27 seconds ago